If you immediately hit the Skip Ads, it's no longer considered, as YouTube calls it, an "engaged-view conversation," and the creator won't receive any of the ad money that would be owed to them if you ...

US Supreme Court to hear 'skinny label' patent fight involving Amarin The U.S. Supreme Court agreed on Friday to hear a patent dispute involving Amarin Pharma's cardiovascular drug Vascepa that could ...